America can either cede the future of biotechnology to our adversaries or summon the vision and resolve to lead it.

Picture a world where most life-saving medicines are discovered not in the United States, but in Beijing and Shanghai. Imagine a time when the most advanced biotechnologies, therapies that cure ...

Translational study shows that multiple immunological biomarkers predict the clinical activity of PDS0101 combination therapy PDS01ADC reprograms natural killer (NK) cells to possess characteristics ...

Company Announced Completion of VERSATILE-002 Phase 2 trial of PDS0101 + Pembrolizumab in HPV16-Positive Recurrent/Metastatic Head and Neck ...

Star Minerals have entered into a right-to-mine agreement with mining contractor MEGA Resources and Bain Global Resources for ...

Initiated development of a second CAPTN-3 tri-specific antibody targeting TROP2 Manufacturing milestone achieved for IM1240, the first ...

Detailed price information for Legend Biotech Corp ADR (LEGN-Q) from The Globe and Mail including charting and trades.

CELLerate, a manufacturer of assay-ready frozen cells has established an agreement with ATCC a global biological resource and standards organization. Under the agreement, acCELLerate will produce ...

The Novo Nordisk Foundation in Denmark, one of the world’s leading funders of pharmaceutical and biotechnology research, is investing €21.7 million to support emerging and rising Danish researchers in ...

Curis, Inc. , a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and FLT3 inhibitor, today reported its financial and operating ...